| 1 | A common form of dominant human IFNAR1 deficiency impairs IFN-α and -ω but not IFN-β-dependent immunity | 9.3 | 12 | Citations (PDF) |
| 2 | Hepatitis B Virus Nucleocapsid Assembly | 4.1 | 4 | Citations (PDF) |
| 3 | Pan-viral ORFs discovery using massively parallel ribosome profiling | 36.3 | 3 | Citations (PDF) |
| 4 | An enhanced Eco1 retron editor enables precision genome engineering in human cells without double-strand breaks | 15.5 | 2 | Citations (PDF) |
| 5 | The antiviral state of the cell: lessons from SARS-CoV-2 | 5.2 | 20 | Citations (PDF) |
| 6 | Increased Protein Kinase A Activity Induces Fibrolamellar Hepatocellular Carcinoma Features Independent of DNAJB1 | 3.8 | 13 | Citations (PDF) |
| 7 | Distinct pathways for evolution of enhanced receptor binding and cell entry in SARS-like bat coronaviruses | 4.4 | 7 | Citations (PDF) |
| 8 | Inborn errors of OAS–RNase L in SARS-CoV-2–related multisystem inflammatory syndrome in children | 36.3 | 147 | Citations (PDF) |
| 9 | Characterization of Live-Attenuated Powassan Virus Vaccine Candidates Identifies an Efficacious Prime-Boost Strategy for Mitigating Powassan Virus Disease in a Murine Model | 2.9 | 17 | Citations (PDF) |
| 10 | An RNA-based system to study hepatitis B virus replication and evaluate antivirals | 10.9 | 18 | Citations (PDF) |
| 11 | Mechanisms of Action of the Host-Targeting Agent Cyclosporin A and Direct-Acting Antiviral Agents against Hepatitis C Virus | 3.2 | 3 | Citations (PDF) |
| 12 | Autoantibodies neutralizing type I IFNs underlie West Nile virus encephalitis in ∼40% of patients | 9.3 | 113 | Citations (PDF) |
| 13 | OX40L-expressing recombinant modified vaccinia virus Ankara induces potent antitumor immunity via reprogramming Tregs | 9.3 | 21 | Citations (PDF) |
| 14 | Pan-sarbecovirus prophylaxis with human anti-ACE2 monoclonal antibodies | 16.0 | 17 | Citations (PDF) |
| 15 | Human FcγRIIIa activation on splenic macrophages drives dengue pathogenesis in mice | 16.0 | 31 | Citations (PDF) |
| 16 | Challenge Inoculum for Hepatitis C Virus Controlled Human Infection Model | 5.2 | 6 | Citations (PDF) |
| 17 | Heteromultimeric sarbecovirus receptor binding domain immunogens primarily generate variant-specific neutralizing antibodies | 7.5 | 5 | Citations (PDF) |
| 18 | System-wide transcriptome damage and tissue identity loss in COVID-19 patients | 6.6 | 39 | Citations (PDF) |
| 19 | Sindbis Macrodomain Poly-ADP-Ribose Hydrolase Activity Is Important for Viral RNA Synthesis | 3.6 | 9 | Citations (PDF) |
| 20 | Lung type II alveolar epithelial cells collaborate with CCR2+ inflammatory monocytes in host defense against poxvirus infection | 13.7 | 23 | Citations (PDF) |
| 21 | Proteomic elucidation of the targets and primary functions of the picornavirus 2A protease | 2.2 | 26 | Citations (PDF) |
| 22 | Analysis of memory B cells identifies conserved neutralizing epitopes on the N-terminal domain of variant SARS-Cov-2 spike proteins | 22.6 | 163 | Citations (PDF) |
| 23 | Mouse characteristics that affect establishing xenografts from hepatocellular carcinoma patient biopsies in the United States | 2.6 | 3 | Citations (PDF) |
| 24 | Neutralization and receptor use of infectious culture–derived rat hepacivirus as a model for HCV | 10.1 | 23 | Citations (PDF) |
| 25 | The risk of COVID-19 death is much greater and age dependent with type I IFN autoantibodies | 7.5 | 182 | Citations (PDF) |
| 26 | Common human genetic variants of APOE impact murine COVID-19 mortality | 37.9 | 57 | Citations (PDF) |
| 27 | Cell-impermeable staurosporine analog targets extracellular kinases to inhibit HSV and SARS-CoV-2 | 4.4 | 5 | Citations (PDF) |
| 28 | Spatial omics technologies at multimodal and single cell/subcellular level | 8.1 | 109 | Citations (PDF) |
| 29 | Enhanced SARS-CoV-2 neutralization by dimeric IgA | 12.5 | 494 | Citations (PDF) |
| 30 | TMEM41B Is a Pan-flavivirus Host FactorCell, 2021, 184, 133-148.e20 | 33.6 | 204 | Citations (PDF) |
| 31 | Genome-Scale Identification of SARS-CoV-2 and Pan-coronavirus Host Factor NetworksCell, 2021, 184, 120-132.e14 | 33.6 | 429 | Citations (PDF) |
| 32 | A selectable, plasmid-based system to generate CRISPR/Cas9 gene edited and knock-in mosquito cell lines | 3.4 | 13 | Citations (PDF) |
| 33 | Functional interrogation of a SARS-CoV-2 host protein interactome identifies unique and shared coronavirus host factors | 15.1 | 167 | Citations (PDF) |
| 34 | Quantitative measurements of early alphaviral replication dynamics in single cells reveals the basis for superinfection exclusion | 5.8 | 23 | Citations (PDF) |
| 35 | Decoupling expression and editing preferences of ADAR1 p150 and p110 isoforms | 7.5 | 104 | Citations (PDF) |
| 36 | Broad and potent neutralizing human antibodies to tick-borne flaviviruses protect mice from disease | 9.3 | 56 | Citations (PDF) |
| 37 | Argonaute-CLIP delineates versatile, functional RNAi networks in Aedes aegypti, a major vector of human viruses | 15.1 | 17 | Citations (PDF) |
| 38 | DRUL for school: Opening Pre-K with safe, simple, sensitive saliva testing for SARS-CoV-2 | 2.3 | 7 | Citations (PDF) |
| 39 | Pathogenesis, MicroRNA‐122 Gene‐Regulation, and Protective Immune Responses After Acute Equine Hepacivirus Infection | 10.1 | 22 | Citations (PDF) |
| 40 | Identification of Novel Therapeutic Targets for Fibrolamellar Carcinoma Using Patient-Derived Xenografts and Direct-from-Patient Screening | 25.1 | 44 | Citations (PDF) |
| 41 | Naturally enhanced neutralizing breadth against SARS-CoV-2 one year after infection | 37.9 | 724 | Citations (PDF) |
| 42 | Profiling SARS-CoV-2 HLA-I peptidome reveals T cell epitopes from out-of-frame ORFsCell, 2021, 184, 3962-3980.e17 | 33.6 | 145 | Citations (PDF) |
| 43 | Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths | 13.4 | 557 | Citations (PDF) |
| 44 | Fc-engineered antibody therapeutics with improved anti-SARS-CoV-2 efficacy | 37.9 | 195 | Citations (PDF) |
| 45 | E3 ubiquitin ligase Mindbomb 1 facilitates nuclear delivery of adenovirus genomes | 7.5 | 17 | Citations (PDF) |
| 46 | Replication and single-cycle delivery of SARS-CoV-2 replicons | 36.3 | 80 | Citations (PDF) |
| 47 | A CRISPR Activation Screen Identifies an Atypical Rho GTPase That Enhances Zika Viral Entry | 3.2 | 21 | Citations (PDF) |
| 48 | Human IFIT3 Protein Induces Interferon Signaling and Inhibits Adenovirus Immediate Early Gene Expression | 4.4 | 50 | Citations (PDF) |
| 49 | Metabolites with SARS-CoV-2 Inhibitory Activity Identified from Human Microbiome Commensals | 3.0 | 25 | Citations (PDF) |
| 50 | Development of antibody-based assays for high throughput discovery and mechanistic study of antiviral agents against yellow fever virus | 3.8 | 9 | Citations (PDF) |
| 51 | Defining the proteolytic landscape during enterovirus infection | 4.4 | 46 | Citations (PDF) |
| 52 | Downregulation of IGF2 expression in third trimester placental tissues from Zika virus infected women in Brazil | 2.8 | 4 | Citations (PDF) |
| 53 | Generation of a reporter yellow fever virus for high throughput antiviral assays | 3.8 | 26 | Citations (PDF) |
| 54 | Equine pegiviruses cause persistent infection of bone marrow and are not associated with hepatitis | 4.4 | 22 | Citations (PDF) |
| 55 | RTP4 inhibits IFN-I response and enhances experimental cerebral malaria and neuropathology | 7.5 | 52 | Citations (PDF) |
| 56 | Convergent antibody responses to SARS-CoV-2 in convalescent individuals | 37.9 | 1,976 | Citations (PDF) |
| 57 | LY6E impairs coronavirus fusion and confers immune control of viral disease | 16.0 | 223 | Citations (PDF) |
| 58 | Measuring SARS-CoV-2 neutralizing antibody activity using pseudotyped and chimeric viruses | 9.3 | 618 | Citations (PDF) |
| 59 | Inborn errors of type I IFN immunity in patients with life-threatening COVID-19 | 36.3 | 2,066 | Citations (PDF) |
| 60 | Autoantibodies against type I IFNs in patients with life-threatening COVID-19 | 36.3 | 2,448 | Citations (PDF) |
| 61 | Liver-expressed
Cd302
and
Cr1l
limit hepatitis C virus cross-species transmission to mice | 10.9 | 33 | Citations (PDF) |
| 62 | Identification of interferon-stimulated genes that attenuate Ebola virus infection | 13.7 | 48 | Citations (PDF) |
| 63 | A Combination of Human Broadly Neutralizing Antibodies against Hepatitis B Virus HBsAg with Distinct Epitopes Suppresses Escape Mutations | 15.1 | 74 | Citations (PDF) |
| 64 | Expansion, in vivo–ex vivo cycling, and genetic manipulation of primary human hepatocytes | 7.5 | 61 | Citations (PDF) |
| 65 | Control of human hemoglobin switching by LIN28B-mediated regulation of BCL11A translation | 25.2 | 107 | Citations (PDF) |
| 66 | A combination of two human monoclonal antibodies limits fetal damage by Zika virus in macaques | 7.5 | 34 | Citations (PDF) |
| 67 | Structural basis for Zika envelope domain III recognition by a germline version of a recurrent neutralizing antibody | 7.5 | 11 | Citations (PDF) |
| 68 | Stem cell-derived polarized hepatocytes | 13.7 | 99 | Citations (PDF) |
| 69 | Risk of Zika microcephaly correlates with features of maternal antibodies | 9.3 | 54 | Citations (PDF) |
| 70 | Replicons of a Rodent Hepatitis C Model Virus Permit Selection of Highly Permissive Cells | 3.6 | 24 | Citations (PDF) |
| 71 | Inherited IFNAR1 deficiency in otherwise healthy patients with adverse reaction to measles and yellow fever live vaccines | 9.3 | 175 | Citations (PDF) |
| 72 | Inherited IL-18BP deficiency in human fulminant viral hepatitis | 9.3 | 104 | Citations (PDF) |
| 73 | ZAP’s stress granule localization is correlated with its antiviral activity and induced by virus replication | 4.4 | 50 | Citations (PDF) |
| 74 | Characterization of Novel Splice Variants of Zinc Finger Antiviral Protein (ZAP) | 3.6 | 92 | Citations (PDF) |
| 75 | Identification and transcriptome analysis of erythroblastic island macrophagesBlood, 2019, 134, 480-491 | 4.8 | 152 | Citations (PDF) |
| 76 | A protein-interaction network of interferon-stimulated genes extends the innate immune system landscape | 23.5 | 200 | Citations (PDF) |
| 77 | Taming a beast: lessons from the domestication of hepatitis C virus | 5.0 | 11 | Citations (PDF) |
| 78 | Visualization of Positive and Negative Sense Viral RNA for Probing the Mechanism of Direct-Acting Antivirals against Hepatitis C Virus | 3.2 | 17 | Citations (PDF) |
| 79 | IFITM3 directly engages and shuttles incoming virus particles to lysosomes | 11.8 | 225 | Citations (PDF) |
| 80 | Antiviral resistance of stem cells | 5.2 | 34 | Citations (PDF) |
| 81 | Stem Cell–Derived Culture Models of Hepatitis E Virus Infection | 6.6 | 20 | Citations (PDF) |
| 82 | Investigating the functional link between TMEM165 and SPCA1 | 3.8 | 16 | Citations (PDF) |
| 83 | Critical challenges and emerging opportunities in hepatitis C virus research in an era of potent antiviral therapy: Considerations for scientists and funding agencies | 2.6 | 157 | Citations (PDF) |
| 84 | Human ADAR1 Prevents Endogenous RNA from Triggering Translational ShutdownCell, 2018, 172, 811-824.e14 | 33.6 | 538 | Citations (PDF) |
| 85 | Genetic Variation at IFNL4 Influences Extrahepatic Interferon-Stimulated Gene Expression in Chronic HCV Patients | 3.7 | 20 | Citations (PDF) |
| 86 | Pan-Genotype Hepatitis E Virus Replication in Stem Cell–Derived Hepatocellular Systems | 0.9 | 66 | Citations (PDF) |
| 87 | Interferon-Stimulated Gene (ISG)-Expression Screening Reveals the Specific Antibunyaviral Activity of ISG20 | 3.6 | 56 | Citations (PDF) |
| 88 | Viral persistence, liver disease, and host response in a hepatitis C–like virus rat model | 10.1 | 80 | Citations (PDF) |
| 89 | Intrinsic Immunity Shapes Viral Resistance of Stem CellsCell, 2018, 172, 423-438.e25 | 33.6 | 379 | Citations (PDF) |
| 90 | Identification of a Small Interface between the Methyltransferase and RNA Polymerase of NS5 that is Essential for Zika Virus Replication | 3.4 | 13 | Citations (PDF) |
| 91 | Long-Term Expansion of Functional Mouse and Human Hepatocytes as 3D OrganoidsCell, 2018, 175, 1591-1606.e19 | 33.6 | 771 | Citations (PDF) |
| 92 | New Parvovirus Associated with Serum Hepatitis in Horses after Inoculation of Common Biological Product | 3.8 | 95 | Citations (PDF) |
| 93 | Longitudinal transcriptomic characterization of the immune response to acute hepatitis C virus infection in patients with spontaneous viral clearance | 4.4 | 41 | Citations (PDF) |
| 94 | Male germ cells support long-term propagation of Zika virus | 13.7 | 92 | Citations (PDF) |
| 95 | Internal Disequilibria and Phenotypic Diversification during Replication of Hepatitis C Virus in a Noncoevolving Cellular Environment | 3.6 | 48 | Citations (PDF) |
| 96 | Single‐molecule imaging reveals the translocation and DNA looping dynamics of hepatitis C virus NS3 helicase | 5.9 | 19 | Citations (PDF) |
| 97 | Tumor Necrosis Factor Inhibits Spread of Hepatitis C Virus Among Liver Cells, Independent From Interferons | 0.9 | 23 | Citations (PDF) |
| 98 | Recurrent Potent Human Neutralizing Antibodies to Zika Virus in Brazil and MexicoCell, 2017, 169, 597-609.e11 | 33.6 | 335 | Citations (PDF) |
| 99 | The IFN-λ-IFN-λR1-IL-10Rβ Complex Reveals Structural Features Underlying Type III IFN Functional Plasticity | 22.6 | 120 | Citations (PDF) |
| 100 | Global mapping of miRNA-target interactions in cattle (Bos taurus) | 3.4 | 26 | Citations (PDF) |
| 101 | Differential Regulation of Lipoprotein and Hepatitis C Virus Secretion by Rab1b | 6.3 | 33 | Citations (PDF) |
| 102 | Diverse Viruses Require the Calcium Transporter SPCA1 for Maturation and Spread | 15.1 | 60 | Citations (PDF) |
| 103 | Development of a recombinant yellow fever vector expressing a HIV clade C founder envelope gp120 | 1.6 | 2 | Citations (PDF) |
| 104 | Argonaute CLIP Defines a Deregulated miR-122-Bound Transcriptome that Correlates with Patient Survival in Human Liver Cancer | 13.3 | 81 | Citations (PDF) |
| 105 | Cycluridine: A novel antiviral effective against flaviviruses | 0.8 | 3 | Citations (PDF) |
| 106 | In situ expansion of engineered human liver tissue in a mouse model of chronic liver disease | 12.5 | 164 | Citations (PDF) |
| 107 | A robust cell culture system supporting the complete life cycle of hepatitis B virus | 3.4 | 77 | Citations (PDF) |
| 108 | Effects of amino acid substitutions in hepatitis B virus surface protein on virion secretion, antigenicity, HBsAg and viral DNA | 4.2 | 75 | Citations (PDF) |
| 109 | TRIM25 Enhances the Antiviral Action of Zinc-Finger Antiviral Protein (ZAP) | 4.4 | 213 | Citations (PDF) |
| 110 | Loss of Sendai virus C protein leads to accumulation of RIG-I immunostimulatory defective interfering RNA | 3.3 | 32 | Citations (PDF) |
| 111 | miRNA independent hepacivirus variants suggest a strong evolutionary pressure to maintain miR-122 dependence | 4.4 | 27 | Citations (PDF) |
| 112 | Lethal Mutagenesis of Hepatitis C Virus Induced by Favipiravir | 2.3 | 69 | Citations (PDF) |
| 113 | The Spring α-Helix Coordinates Multiple Modes of HCV (Hepatitis C Virus) NS3 Helicase Action | 2.2 | 16 | Citations (PDF) |
| 114 | Interferon regulatory factor 2 protects mice from lethal viral neuroinvasion | 9.3 | 21 | Citations (PDF) |
| 115 | Freeze Drying Method with Gaseous Nitrogen to Preserve Fine Ultrastructure of Biological Organizations for Scanning Electron Microscopy, Helium Ion Beam Microscopy and Fluorescence Microscopy | 0.4 | 3 | Citations (PDF) |
| 116 | Superior In vivo Transduction of Human Hepatocytes Using Engineered AAV3 Capsid | 10.2 | 111 | Citations (PDF) |
| 117 | Barrier-Independent, Fitness-Associated Differences in Sofosbuvir Efficacy against Hepatitis C Virus | 4.1 | 51 | Citations (PDF) |
| 118 | Humanized mice efficiently engrafted with fetal hepatoblasts and syngeneic immune cells develop human monocytes and NK cells | 4.2 | 86 | Citations (PDF) |
| 119 | Viral genome imaging of hepatitis C virus to probe heterogeneous viral infection and responses to antiviral therapies | 2.3 | 19 | Citations (PDF) |
| 120 | Sindbis Virus Can Exploit a Host Antiviral Protein To Evade Immune Surveillance | 3.6 | 20 | Citations (PDF) |
| 121 | Identification of Interferon-Stimulated Genes with Antiretroviral Activity | 15.1 | 279 | Citations (PDF) |
| 122 | Expanding the Host Range of Hepatitis C Virus through Viral Adaptation | 4.4 | 16 | Citations (PDF) |
| 123 | Chaperone-Assisted Protein Folding Is Critical for Yellow Fever Virus NS3/4A Cleavage and Replication | 3.6 | 28 | Citations (PDF) |
| 124 | Proteomics of HCV virions reveals an essential role for the nucleoporin Nup98 in virus morphogenesis | 7.5 | 67 | Citations (PDF) |
| 125 | A Broad RNA Virus Survey Reveals Both miRNA Dependence and Functional Sequestration | 15.1 | 131 | Citations (PDF) |
| 126 | Sofosbuvir Inhibits Hepatitis E Virus Replication In Vitro and Results in an Additive Effect When Combined With Ribavirin | 0.9 | 204 | Citations (PDF) |
| 127 | Tuning a cellular lipid kinase activity adapts hepatitis C virus to replication in cell culture | 16.0 | 56 | Citations (PDF) |
| 128 | Repurposing an old drug: A low‐cost allergy medication provides new hope for hepatitis C patients | 10.1 | 3 | Citations (PDF) |
| 129 | Screening of the Pan-African Natural Product Library Identifies Ixoratannin A-2 and Boldine as Novel HIV-1 Inhibitors | 2.3 | 44 | Citations (PDF) |
| 130 | CRISPR/Cas9 cleavage of viral DNA efficiently suppresses hepatitis B virus | 3.4 | 280 | Citations (PDF) |
| 131 | Hepatitis B virus induces RNR-R2 expression via DNA damage response activation | 4.2 | 36 | Citations (PDF) |
| 132 | Quantitative Proteomics Identifies Serum Response Factor Binding Protein 1 as a Host Factor for Hepatitis C Virus Entry | 6.3 | 57 | Citations (PDF) |
| 133 | A Serpin Shapes the Extracellular Environment to Prevent Influenza A Virus Maturation | 33.6 | 165 | Citations (PDF) |
| 134 | Characterization of nonprimate hepacivirus and construction of a functional molecular clone | 7.5 | 99 | Citations (PDF) |
| 135 | Interferons and viruses: an evolutionary arms race of molecular interactions | 10.4 | 423 | Citations (PDF) |
| 136 | Hepatitis C Virus RNA Functionally Sequesters miR-122Cell, 2015, 160, 1099-1110 | 33.6 | 351 | Citations (PDF) |
| 137 | Identification, Molecular Cloning, and Analysis of Full-Length Hepatitis C Virus Transmitted/Founder Genotypes 1, 3, and 4 | 4.4 | 17 | Citations (PDF) |
| 138 | Interferon-γ regulates cellular metabolism and mRNA translation to potentiate macrophage activation | 23.5 | 298 | Citations (PDF) |
| 139 | ATP-Dependent Effector-like Functions of RIG-I-like Receptors | 13.3 | 70 | Citations (PDF) |
| 140 | To translate, or not to translate: viral and host mRNA regulation by interferon-stimulated genes | 12.0 | 95 | Citations (PDF) |
| 141 | Hepatitis C virus infects rhesus macaque hepatocytes and simianized mice | 10.1 | 24 | Citations (PDF) |
| 142 | Fast Hepatitis C Virus RNA Elimination and NS5A Redistribution by NS5A Inhibitors Studied by a Multiplex Assay Approach | 4.1 | 20 | Citations (PDF) |
| 143 | SEC14L2 enables pan-genotype HCV replication in cell culture | 37.9 | 122 | Citations (PDF) |
| 144 | miRNA–target chimeras reveal miRNA 3′-end pairing as a major determinant of Argonaute target specificity | 13.7 | 327 | Citations (PDF) |
| 145 | The RNA Sensor RIG-I Dually Functions as an Innate Sensor and Direct Antiviral Factor for Hepatitis B Virus | 22.6 | 402 | Citations (PDF) |
| 146 | In memoriam – Richard M. Elliott (1954–2015) | 3.3 | 4 | Citations (PDF) |
| 147 | The N-terminal Helical Region of the Hepatitis C Virus p7 Ion Channel Protein Is Critical for Infectious Virus Production | 4.4 | 19 | Citations (PDF) |
| 148 | New Methods in Tissue Engineering: Improved Models for Viral Infection | 7.5 | 25 | Citations (PDF) |
| 149 | Multifaceted Activities of Type I Interferon Are Revealed by a Receptor Antagonist | 5.4 | 116 | Citations (PDF) |
| 150 | Insufficient interleukin‐12 signalling favours differentiation of human CD4+ and CD8+ T cells into GATA‐3+ and GATA‐3+ T‐bet+ subsets in humanized mice | 4.7 | 24 | Citations (PDF) |
| 151 | Broadly neutralizing antibodies abrogate established hepatitis C virus infection | 12.5 | 220 | Citations (PDF) |
| 152 | Identification of AP80978, a Novel Small-Molecule Inhibitor of Hepatitis C Virus Replication That Targets NS4B | 4.1 | 22 | Citations (PDF) |
| 153 | Emerging therapies for the treatment of hepatitis C | 7.1 | 98 | Citations (PDF) |
| 154 | Interferon-Stimulated Genes: A Complex Web of Host Defenses | 29.4 | 3,004 | Citations (PDF) |
| 155 | Interferon Lambda Alleles Predict Innate Antiviral Immune Responses and Hepatitis C Virus Permissiveness | 15.1 | 97 | Citations (PDF) |
| 156 | Hepatitis C Virus Genotype 5a Subgenomic Replicons for Evaluation of Direct-Acting Antiviral Agents | 4.1 | 32 | Citations (PDF) |
| 157 | Utility of Humanized BLT Mice for Analysis of Dengue Virus Infection and Antiviral Drug Testing | 3.6 | 59 | Citations (PDF) |
| 158 | Seed Sequence-Matched Controls Reveal Limitations of Small Interfering RNA Knockdown in Functional and Structural Studies of Hepatitis C Virus NS5A-MOBKL1B Interaction | 3.6 | 21 | Citations (PDF) |
| 159 | Increased Replicative Fitness Can Lead to Decreased Drug Sensitivity of Hepatitis C Virus | 3.6 | 86 | Citations (PDF) |
| 160 | Virus associated malignancies: The role of viral hepatitis in hepatocellular carcinoma | 13.7 | 169 | Citations (PDF) |
| 161 | Modeling host interactions with hepatitis B virus using primary and induced pluripotent stem cell-derived hepatocellular systems | 7.5 | 243 | Citations (PDF) |
| 162 | Development of a multiplex phenotypic cell-based high throughput screening assay to identify novel hepatitis C virus antivirals | 3.8 | 15 | Citations (PDF) |
| 163 | Study of hepatitis C virus entry in genetically humanized mice | 3.5 | 17 | Citations (PDF) |
| 164 | The ins and outs of hepatitis C virus entry and assembly | 83.4 | 357 | Citations (PDF) |
| 165 | Understanding the hepatitis C virus life cycle paves the way for highly effective therapies | 33.0 | 535 | Citations (PDF) |
| 166 | Expression of heterologous proteins flanked by NS3-4A cleavage sites within the hepatitis C virus polyprotein | 2.3 | 23 | Citations (PDF) |
| 167 | Mo1783 Personalizing the Study of Infectious Disease: Modeling Hepatitis C Virus Using Induced Pluripotent Stem Cells | 0.9 | 0 | Citations (PDF) |
| 168 | Structures of hepatitis C virus nonstructural proteins required for replicase assembly and function | 5.0 | 50 | Citations (PDF) |
| 169 | Recapitulation of the hepatitis C virus life-cycle in engineered murine cell lines | 2.3 | 66 | Citations (PDF) |
| 170 | Somatic Hypermutations Confer Rheumatoid Factor Activity in Hepatitis C Virus–Associated Mixed Cryoglobulinemia | 6.1 | 48 | Citations (PDF) |
| 171 | Identification of Rodent Homologs of Hepatitis C Virus and Pegiviruses | 4.4 | 201 | Citations (PDF) |
| 172 | Response of Hepatitis C Virus to Long-Term Passage in the Presence of Alpha Interferon: Multiple Mutations and a Common Phenotype | 3.6 | 92 | Citations (PDF) |
| 173 | IFNβ-dependent increases in STAT1, STAT2, and IRF9 mediate resistance to viruses and DNA damage | 7.3 | 332 | Citations (PDF) |
| 174 | Genetic and Functional Characterization of the N-Terminal Region of the Hepatitis C Virus NS2 Protein | 3.6 | 19 | Citations (PDF) |
| 175 | Different Requirements for Scavenger Receptor Class B Type I in Hepatitis C Virus Cell-Free versus Cell-to-Cell Transmission | 3.6 | 85 | Citations (PDF) |
| 176 | Immunotherapy of chronic hepatitis C virus infection with antibodies against programmed cell death-1 (PD-1) | 7.5 | 161 | Citations (PDF) |
| 177 | Ultrastructural analysis of hepatitis C virus particles | 7.5 | 262 | Citations (PDF) |
| 178 | Host-cell sensors for Plasmodium activate innate immunity against liver-stage infection | 33.0 | 290 | Citations (PDF) |
| 179 | Pan-viral specificity of IFN-induced genes reveals new roles for cGAS in innate immunity | 37.9 | 896 | Citations (PDF) |
| 180 | Flavivirus Replication Complex Assembly Revealed by DNAJC14 Functional Mapping | 3.6 | 43 | Citations (PDF) |
| 181 | Efficient Replication of Genotype 3a and 4a Hepatitis C Virus Replicons in Human Hepatoma Cells | 4.1 | 119 | Citations (PDF) |
| 182 | Dengue reporter viruses reveal viral dynamics in interferon receptor-deficient mice and sensitivity to interferon effectors in vitro | 7.5 | 185 | Citations (PDF) |
| 183 | C7L Family of Poxvirus Host Range Genes Inhibits Antiviral Activities Induced by Type I Interferons and Interferon Regulatory Factor 1 | 3.6 | 49 | Citations (PDF) |
| 184 | Modeling hepatitis C virus infection using human induced pluripotent stem cells | 7.5 | 202 | Citations (PDF) |
| 185 | Serology-Enabled Discovery of Genetically Diverse Hepaciviruses in a New Host | 3.6 | 238 | Citations (PDF) |
| 186 | Human broadly neutralizing antibodies to the envelope glycoprotein complex of hepatitis C virus | 7.5 | 339 | Citations (PDF) |
| 187 | Inhibition of HIV-1 Particle Assembly by 2′,3′-Cyclic-Nucleotide 3′-Phosphodiesterase | 15.1 | 60 | Citations (PDF) |
| 188 | Multiple Interferon Stimulated Genes Synergize with the Zinc Finger Antiviral Protein to Mediate Anti-Alphavirus Activity | 2.3 | 74 | Citations (PDF) |
| 189 | Partial clearance of a hepatotropic virus infection in HLA class I and II double transgenic human immune system mice (105.19) | 0.6 | 0 | Citations (PDF) |
| 190 | A Humanized Mouse Model to Study Hepatitis C Virus Infection, Immune Response, and Liver Disease | 0.9 | 291 | Citations (PDF) |
| 191 | Interferon-stimulated genes and their antiviral effector functions | 5.0 | 1,263 | Citations (PDF) |
| 192 | Characterization of a canine homolog of hepatitis C virus | 7.5 | 265 | Citations (PDF) |
| 193 | Turning Hepatitis C into a Real Virus | 9.1 | 54 | Citations (PDF) |
| 194 | Development of human CD4+FoxP3+ regulatory T cells in human stem cell factor–, granulocyte-macrophage colony-stimulating factor–, and interleukin-3–expressing NOD-SCID IL2Rγnull humanized miceBlood, 2011, 117, 3076-3086 | 4.8 | 308 | Citations (PDF) |
| 195 | A diverse range of gene products are effectors of the type I interferon antiviral response | 37.9 | 2,410 | Citations (PDF) |
| 196 | Clonal B cells in patients with hepatitis C virus–associated mixed cryoglobulinemia contain an expanded anergic CD21low B-cell subsetBlood, 2011, 117, 5425-5437 | 4.8 | 196 | Citations (PDF) |
| 197 | Expression of paramyxovirus V proteins promotes replication and spread of hepatitis C virus in cultures of primary human fetal liver cells | 10.1 | 81 | Citations (PDF) |
| 198 | Hepatitis C virus induces interferon-λ and interferon-stimulated genes in primary liver cultures | 10.1 | 163 | Citations (PDF) |
| 199 | Perspective: Miles to go before we sleep | 37.9 | 16 | Citations (PDF) |
| 200 | Hepatitis C Virus Co-Opts Ras-GTPase-Activating Protein-Binding Protein 1 for Its Genome Replication | 3.6 | 60 | Citations (PDF) |
| 201 | Identification and Characterization of the Host Protein DNAJC14 as a Broadly Active Flavivirus Replication Modulator | 4.4 | 77 | Citations (PDF) |
| 202 | Creation and characterization of a cell-death reporter cell line for hepatitis C virus infection | 3.8 | 9 | Citations (PDF) |
| 203 | Teaching New Tricks to an Old Foe | 10.1 | 0 | Citations (PDF) |
| 204 | Real-time imaging of hepatitis C virus infection using a fluorescent cell-based reporter system | 29.8 | 247 | Citations (PDF) |
| 205 | Identification of a Dominant Negative Inhibitor of Human Zinc Finger Antiviral Protein Reveals a Functional Endogenous Pool and Critical Homotypic Interactions | 3.6 | 30 | Citations (PDF) |
| 206 | Persistent hepatitis C virus infection in microscale primary human hepatocyte cultures | 7.5 | 191 | Citations (PDF) |
| 207 | A cell protection screen reveals potent inhibitors of multiple stages of the hepatitis C virus life cycle | 7.5 | 76 | Citations (PDF) |
| 208 | Host Factors Associated with the Sindbis Virus RNA-Dependent RNA Polymerase: Role for G3BP1 and G3BP2 in Virus Replication | 3.6 | 111 | Citations (PDF) |
| 209 | Splicing Diversity of the Human
OCLN
Gene and Its Biological Significance for Hepatitis C Virus Entry | 3.6 | 33 | Citations (PDF) |
| 210 | Genetic Analysis of the Carboxy-Terminal Region of the Hepatitis C Virus Core Protein | 3.6 | 39 | Citations (PDF) |
| 211 | Three conformational snapshots of the hepatitis C virus NS3 helicase reveal a ratchet translocation mechanism | 7.5 | 236 | Citations (PDF) |
| 212 | Immunogenicity and protective efficacy of a recombinant yellow fever vaccine against the murine malarial parasite Plasmodium yoelii | 3.1 | 23 | Citations (PDF) |
| 213 | Evaluation of yellow fever virus 17D strain as a new vector for HIV-1 vaccine development | 3.1 | 28 | Citations (PDF) |
| 214 | Determinants of the Hepatitis C Virus Nonstructural Protein 2 Protease Domain Required for Production of Infectious Virus | 3.6 | 51 | Citations (PDF) |
| 215 | Genomic Analysis Reveals a Potential Role for Cell Cycle Perturbation in HCV-Mediated Apoptosis of Cultured Hepatocytes | 4.4 | 108 | Citations (PDF) |
| 216 | Internal Initiation Stimulates Production of p8 Minicore, a Member of a Newly Discovered Family of Hepatitis C Virus Core Protein Isoforms | 3.6 | 37 | Citations (PDF) |
| 217 | Towards a small animal model for hepatitis C | 5.2 | 69 | Citations (PDF) |
| 218 | Human occludin is a hepatitis C virus entry factor required for infection of mouse cells | 37.9 | 855 | Citations (PDF) |
| 219 | Cell culture–produced hepatitis C virus does not infect peripheral blood mononuclear cells | 10.1 | 226 | Citations (PDF) |
| 220 | Architects of assembly: roles of Flaviviridae non-structural proteins in virion morphogenesis | 83.4 | 219 | Citations (PDF) |
| 221 | Hepatitis C Virus Entry | 2.2 | 90 | Citations (PDF) |
| 222 | Identification of Residues Required for RNA Replication in Domains II and III of the Hepatitis C Virus NS5A Protein | 3.6 | 177 | Citations (PDF) |
| 223 | Transdominant Inhibition of Bovine Viral Diarrhea Virus Entry | 3.6 | 19 | Citations (PDF) |
| 224 | Stable Cytotoxic T Cell Escape Mutation in Hepatitis C Virus Is Linked to Maintenance of Viral Fitness | 4.4 | 78 | Citations (PDF) |
| 225 | 3′ RNA Elements in Hepatitis C Virus Replication: Kissing Partners and Long Poly(U) | 3.6 | 126 | Citations (PDF) |
| 226 | Bovine Viral Diarrhea Virus Core Is an Intrinsically Disordered Protein That Binds RNA | 3.6 | 44 | Citations (PDF) |
| 227 | A Dynamic View of Hepatitis C Virus Replication Complexes | 3.6 | 124 | Citations (PDF) |
| 228 | Clonal expansion of immunoglobulin M+CD27+ B cells in HCV-associated mixed cryoglobulinemiaBlood, 2008, 111, 1344-1356 | 4.8 | 154 | Citations (PDF) |
| 229 | Superinfection Exclusion in Cells Infected with Hepatitis C Virus | 3.6 | 140 | Citations (PDF) |
| 230 | Hepatitis C Virus p7 and NS2 Proteins Are Essential for Production of Infectious Virus | 3.6 | 416 | Citations (PDF) |
| 231 | Plasmacytoid dendritic cells initiate a complex chemokine and cytokine network and are a viable drug target in chronic HCV patients | 9.3 | 127 | Citations (PDF) |
| 232 | Evidence for a functional RNA element in the hepatitis C virus core gene | 7.5 | 120 | Citations (PDF) |
| 233 | The C Terminus of Hepatitis C Virus NS4A Encodes an Electrostatic Switch That Regulates NS5A Hyperphosphorylation and Viral Replication | 3.6 | 100 | Citations (PDF) |
| 234 | Alanine Scanning of the Hepatitis C Virus Core Protein Reveals Numerous Residues Essential for Production of Infectious Virus | 3.6 | 105 | Citations (PDF) |
| 235 | Mathematical Modeling of Subgenomic Hepatitis C Virus Replication in Huh-7 Cells | 3.6 | 106 | Citations (PDF) |
| 236 | Studying Hepatitis C Virus: Making the Best of a Bad Virus | 3.6 | 124 | Citations (PDF) |
| 237 | Dendritic-cell maturation alters intracellular signaling networks, enabling differential effects of IFN-α/β on antigen cross-presentationBlood, 2007, 109, 1113-1122 | 4.8 | 63 | Citations (PDF) |
| 238 | Flying Under the Radar: The Immunobiology of Hepatitis C | 29.4 | 283 | Citations (PDF) |
| 239 | Hepatitis C Virus Continuously Escapes From Neutralizing Antibody and T-Cell Responses During Chronic Infection In Vivo | 0.9 | 378 | Citations (PDF) |
| 240 | Replication of hepatitis C virus | 83.4 | 1,200 | Citations (PDF) |
| 241 | Claudin-1 is a hepatitis C virus co-receptor required for a late step in entry | 37.9 | 1,130 | Citations (PDF) |
| 242 | Silencing of USP18 Potentiates the Antiviral Activity of Interferon Against Hepatitis C Virus Infection | 0.9 | 169 | Citations (PDF) |
| 243 | Interferons α and λ Inhibit Hepatitis C Virus Replication With Distinct Signal Transduction and Gene Regulation Kinetics | 0.9 | 554 | Citations (PDF) |
| 244 | Foxp3+CD4+CD25+ T cells control virus-specific memory T cells in chimpanzees that recovered from hepatitis CBlood, 2006, 107, 4424-4432 | 4.8 | 118 | Citations (PDF) |
| 245 | Structure of the catalytic domain of the hepatitis C virus NS2-3 protease | 37.9 | 181 | Citations (PDF) |
| 246 | Oxidized low-density lipoprotein inhibits hepatitis C virus cell entry in human hepatoma cells | 10.1 | 119 | Citations (PDF) |
| 247 | Diverse CD81 Proteins Support Hepatitis C Virus Infection | 3.6 | 155 | Citations (PDF) |
| 248 | Time- and Temperature-Dependent Activation of Hepatitis C Virus for Low-pH-Triggered Entry | 3.6 | 353 | Citations (PDF) |
| 249 | The NS5A Protein of Bovine Viral Diarrhea Virus Contains an Essential Zinc-Binding Site Similar to That of the Hepatitis C Virus NS5A Protein | 3.6 | 52 | Citations (PDF) |
| 250 | Tracking and Elucidating Alphavirus-Host Protein Interactions | 2.2 | 179 | Citations (PDF) |
| 251 | Virus-induced type I IFN stimulates generation of immunoproteasomes at the site of infection | 10.6 | 161 | Citations (PDF) |
| 252 | Structure of the zinc-binding domain of an essential component of the hepatitis C virus replicase | 37.9 | 467 | Citations (PDF) |
| 253 | Unravelling hepatitis C virus replication from genome to function | 37.9 | 751 | Citations (PDF) |
| 254 | Treating hepatitis C: Can you teach old dogs new tricks? | 10.1 | 17 | Citations (PDF) |
| 255 | Yellow fever 17D as a vaccine vector for microbial CTL epitopes | 9.3 | 63 | Citations (PDF) |
| 256 | Requirements at the 3′ End of the
Sindbis Virus
Genome for Efficient Synthesis of Minus-Strand RNA | 3.6 | 63 | Citations (PDF) |
| 257 | Dual Mechanisms of Pestiviral Superinfection Exclusion at Entry and RNA Replication | 3.6 | 107 | Citations (PDF) |
| 258 | Normal Functional Capacity in Circulating Myeloid and Plasmacytoid Dendritic Cells in Patients with Chronic Hepatitis C | 3.7 | 119 | Citations (PDF) |
| 259 | Liver-Directed Gamma Interferon Gene Delivery in Chronic Hepatitis C | 3.6 | 27 | Citations (PDF) |
| 260 | Mathematical modeling of primary hepatitis C infection: Noncytolytic clearance and early blockage of virion production | 0.9 | 120 | Citations (PDF) |
| 261 | PKR-Dependent and -Independent Mechanisms Are Involved in Translational Shutoff during Sindbis Virus Infection | 3.6 | 133 | Citations (PDF) |
| 262 | Hepatitis C Virus Core Protein Associates with Detergent-Resistant Membranes Distinct from Classical Plasma Membrane Rafts | 3.6 | 45 | Citations (PDF) |
| 263 | 18. THE MOLECULAR VIROLOGY OF HEPATITIS C VIRUS | 0.0 | 1 | Citations (PDF) |
| 264 | Selection of Functional 5′
cis
-Acting Elements Promoting Efficient Sindbis Virus Genome Replication | 3.6 | 70 | Citations (PDF) |
| 265 | Genetic Interactions between Hepatitis C Virus Replicons | 3.6 | 34 | Citations (PDF) |
| 266 | Uncleaved NS2-3 Is Required for Production of Infectious Bovine Viral Diarrhea Virus | 3.6 | 79 | Citations (PDF) |
| 267 | CD81 Is Required for Hepatitis C Virus Glycoprotein-Mediated Viral Infection | 3.6 | 331 | Citations (PDF) |
| 268 | Characterization of Infectious Retroviral Pseudotype Particles Bearing Hepatitis C Virus Glycoproteins | 3.6 | 90 | Citations (PDF) |
| 269 | An N-Terminal Amphipathic Helix in Hepatitis C Virus (HCV) NS4B Mediates Membrane Association, Correct Localization of Replication Complex Proteins, and HCV RNA Replication | 3.6 | 149 | Citations (PDF) |
| 270 | Induction of interferon-stimulated gene expression and antiviral responses require protein deacetylase activity | 7.5 | 208 | Citations (PDF) |
| 271 | Neutralizing antibody response during acute and chronic hepatitis C virus infection | 7.5 | 390 | Citations (PDF) |
| 272 | The NS5A Protein of Hepatitis C Virus Is a Zinc Metalloprotein | 2.2 | 305 | Citations (PDF) |
| 273 | A
cis
-Acting Replication Element in the Sequence Encoding the NS5B RNA-Dependent RNA Polymerase Is Required for Hepatitis C Virus RNA Replication | 3.6 | 212 | Citations (PDF) |
| 274 | Phosphorylation of hepatitis C virus nonstructural protein 5A modulates its protein interactions and viral RNA replication | 7.5 | 290 | Citations (PDF) |
| 275 | Hepatitis C virus kinetics and host responses associated with disease and outcome of infection in chimpanzees | 10.1 | 142 | Citations (PDF) |
| 276 | Insertion of Green Fluorescent Protein into Nonstructural Protein 5A Allows Direct Visualization of Functional Hepatitis C Virus Replication Complexes | 3.6 | 237 | Citations (PDF) |
| 277 | Interfering with hepatitis C virus RNA replication | 2.6 | 63 | Citations (PDF) |
| 278 | Presence of functional dendritic cells in patients chronically infected with hepatitis C virusBlood, 2004, 103, 1026-1029 | 4.8 | 141 | Citations (PDF) |
| 279 | Evasive Maneuvers by Hepatitits C Virus | 10.1 | 11 | Citations (PDF) |
| 280 | New therapies on the horizon for hepatitis C | 3.5 | 37 | Citations (PDF) |
| 281 | Efficient Replication of Hepatitis C Virus Genotype 1a RNAs in Cell Culture | 3.6 | 323 | Citations (PDF) |
| 282 | Expression of the Zinc-Finger Antiviral Protein Inhibits Alphavirus Replication | 3.6 | 367 | Citations (PDF) |
| 283 | Hepatitis C virus glycoproteins mediate pH-dependent cell entry of pseudotyped retroviral particles | 7.5 | 734 | Citations (PDF) |
| 284 | Clearance of replicating hepatitis C virus replicon RNAs in cell culture by small interfering RNAs | 7.5 | 318 | Citations (PDF) |
| 285 | Development and Application of a Reverse Genetics System for Japanese Encephalitis Virus | 3.6 | 123 | Citations (PDF) |
| 286 | Hepatitis C Virus RNA Synthesis in a Cell-Free System Isolated from Replicon-Containing Hepatoma Cells | 3.6 | 76 | Citations (PDF) |
| 287 | Amphipathic Helix-Dependent Localization of NS5A Mediates Hepatitis C Virus RNA Replication | 3.6 | 161 | Citations (PDF) |
| 288 | Hepatitis C Virus Glycoproteins Interact with DC-SIGN and DC-SIGNR | 3.6 | 353 | Citations (PDF) |
| 289 | Characterization of Vesicular Stomatitis Virus Recombinants That Express and Incorporate High Levels of Hepatitis C Virus Glycoproteins | 3.6 | 87 | Citations (PDF) |
| 290 | Highly Permissive Cell Lines for Subgenomic and Genomic Hepatitis C Virus RNA Replication | 3.6 | 1,147 | Citations (PDF) |
| 291 | Mutations in the Yellow Fever Virus Nonstructural Protein NS2A Selectively Block Production of Infectious Particles | 3.6 | 262 | Citations (PDF) |
| 292 | Roles of Nonstructural Protein nsP2 and Alpha/Beta Interferons in Determining the Outcome of Sindbis Virus Infection | 3.6 | 224 | Citations (PDF) |
| 293 | Interaction between hepatitis C virus proteins and host cell factors | 7.0 | 174 | Citations (PDF) |
| 294 | Induction of hepatitis C virus-specific cytotoxic T lymphocytes in mice by immunization with dendritic cells treated with an anthrax toxin fusion protein | 3.1 | 31 | Citations (PDF) |
| 295 | Hepatitis C virus cell culture replication systems: their potential use for the development of antiviral therapies | 3.3 | 25 | Citations (PDF) |
| 296 | The Hepatitis C Virus Nonstructural Protein 4B Is an Integral Endoplasmic Reticulum Membrane Protein | 2.3 | 187 | Citations (PDF) |
| 297 | Bad time for Bonzo? Experimental models of hepatitis C virus infection, replication, and pathogenesis | 10.1 | 41 | Citations (PDF) |
| 298 | Isolation and Characterization of Noncytopathic Pestivirus Mutants Reveals a Role for Nonstructural Protein NS4B in Viral Cytopathogenicity | 3.6 | 90 | Citations (PDF) |
| 299 | Transcriptional Activation of the Interleukin-2 Promoter by Hepatitis C Virus Core Protein | 3.6 | 71 | Citations (PDF) |
| 300 | Determinants for Membrane Association of the Hepatitis C Virus RNA-dependent RNA Polymerase | 2.2 | 175 | Citations (PDF) |
| 301 | Efficient Translation Initiation Is Required for Replication of Bovine Viral Diarrhea Virus Subgenomic Replicons | 3.6 | 33 | Citations (PDF) |
| 302 | Subcellular Localization, Stability, and
trans
-Cleavage Competence of the Hepatitis C Virus NS3-NS4A Complex Expressed in Tetracycline-Regulated Cell Lines | 3.6 | 252 | Citations (PDF) |
| 303 | Mechanism of action of a pestivirus antiviral compound | 7.5 | 104 | Citations (PDF) |
| 304 | Mutagenesis of the Signal Sequence of Yellow Fever Virus prM Protein: Enhancement of Signalase Cleavage In Vitro Is Lethal for Virus Production | 3.6 | 72 | Citations (PDF) |
| 305 | Hepatitis C Virus-Encoded Enzymatic Activities and Conserved RNA Elements in the 3′ Nontranslated Region Are Essential for Virus Replication In Vivo | 3.6 | 577 | Citations (PDF) |
| 306 | Yellow Fever/Japanese Encephalitis Chimeric Viruses: Construction and Biological Properties | 3.6 | 256 | Citations (PDF) |
| 307 | Identification of the Major Phosphorylation Site of the Hepatitis C Virus H Strain NS5A Protein as Serine 2321 | 2.2 | 65 | Citations (PDF) |
| 308 | Is CD81 the key to hepatitis C virus entry? | 10.1 | 23 | Citations (PDF) |
| 309 | Functionally distinct T-Cell epitopes within the hepatitis C virus non-structural 3 protein | 1.0 | 33 | Citations (PDF) |
| 310 | In vitro human Th-cell responses to a recombinant Hepatitis C Virus antigen: failure in IL-2 production despite proliferation | 1.0 | 47 | Citations (PDF) |
| 311 | Mutagenesis of the NS2B-NS3-Mediated Cleavage Site in the Flavivirus Capsid Protein Demonstrates a Requirement for Coordinated Processing | 3.6 | 103 | Citations (PDF) |
| 312 | Selection of RNA Replicons Capable of Persistent Noncytopathic Replication in Mammalian Cells | 3.6 | 164 | Citations (PDF) |
| 313 | Genetic Interaction of Flavivirus Nonstructural Proteins NS1 and NS4A as a Determinant of Replicase Function | 3.6 | 260 | Citations (PDF) |
| 314 | Continuous human cell lines inducibly expressing hepatitis C virus structural and nonstructural proteins | 10.1 | 150 | Citations (PDF) |
| 315 | Noncytopathic Sindbis virus RNA vectors for heterologous gene expression | 7.5 | 219 | Citations (PDF) |
| 316 | The NS5A/NS5 Proteins of Viruses from Three Genera of the Family
Flaviviridae
Are Phosphorylated by Associated Serine/Threonine Kinases | 3.6 | 134 | Citations (PDF) |
| 317 | West Nile virus envelope proteins: nucleotide sequence analysis of strains differing in mouse neuroinvasiveness. | 3.3 | 111 | Citations (PDF) |
| 318 | Template-Dependent Initiation of Sindbis Virus RNA Replication In Vitro | 3.6 | 90 | Citations (PDF) |
| 319 | Liver-Derived CTL in Hepatitis C Virus Infection: Breadth and Specificity of Responses in a Cohort of Persons with Chronic Infection | 0.6 | 167 | Citations (PDF) |
| 320 | Characterization of truncated forms of hepatitis C virus glycoproteins. | 3.3 | 171 | Citations (PDF) |
| 321 | Mutagenesis of the N-Linked Glycosylation Sites of the Yellow Fever Virus NS1 Protein: Effects on Virus Replication and Mouse Neurovirulence | 2.3 | 160 | Citations (PDF) |
| 322 | Replication of yellow fever virus in the mouse central nervous system: comparison of neuroadapted and non-neuroadapted virus and partial sequence analysis of the neuroadapted strain | 3.3 | 52 | Citations (PDF) |
| 323 | The hepatitis C virus NS3 serine proteinase and NS4A cofactor: establishment of a cell-free trans-processing assay. | 7.5 | 96 | Citations (PDF) |
| 324 | Hepatitis C virus-specific T lymphocyte responses | 5.2 | 38 | Citations (PDF) |
| 325 | Complete nucleotide sequence of yellow fever virus vaccine strains 17DD and 17D-213 | 2.6 | 82 | Citations (PDF) |
| 326 | HLA class I-restricted cytotoxic T lymphocytes specific for hepatitis C virus. Identification of multiple epitopes and characterization of patterns of cytokine release. | 10.6 | 303 | Citations (PDF) |
| 327 | Mutagenesis of the Yellow Fever Virus NS2A/2B Cleavage Site: Effects on Proteolytic Processing, Viral Replication, and Evidence for Alternative Processing of the NS2A Protein | 2.3 | 87 | Citations (PDF) |
| 328 | Deletion and Duplication Mutations in the C-Terminal Nonconserved Region of Sindbis Virus nsP3: Effects on Phosphorylation and on Virus Replication in Vertebrate and Invertebrate Cells | 2.3 | 78 | Citations (PDF) |
| 329 | Formation and intracellular localization of hepatitis C virus envelope glycoprotein complexes expressed by recombinant vaccinia and Sindbis viruses | 3.6 | 393 | Citations (PDF) |
| 330 | Specificity of the hepatitis C virus NS3 serine protease: effects of substitutions at the 3/4A, 4A/4B, 4B/5A, and 5A/5B cleavage sites on polyprotein processing | 3.6 | 130 | Citations (PDF) |
| 331 | Hepatitis C virus NS3 serine proteinase: trans-cleavage requirements and processing kinetics | 3.6 | 209 | Citations (PDF) |
| 332 | NS2B-3 proteinase-mediated processing in the yellow fever virus structural region: in vitro and in vivo studies | 3.6 | 159 | Citations (PDF) |
| 333 | Processing in the hepatitis C virus E2-NS2 region: identification of p7 and two distinct E2-specific products with different C termini | 3.6 | 344 | Citations (PDF) |
| 334 | Mutagenesis of Conserved Residues at the Yellow Fever Virus 3/4A and 4B/5 Dibasic Cleavage Sites: Effects on Cleavage Efficiency and Polyprotein Processing | 2.3 | 52 | Citations (PDF) |
| 335 | A second hepatitis C virus-encoded proteinase. | 7.5 | 427 | Citations (PDF) |
| 336 | Hepatitis C virus NS3 protein polynucleotide-stimulated nucleoside triphosphatase and comparison with the related pestivirus and flavivirus enzymes | 3.6 | 311 | Citations (PDF) |
| 337 | Mutagenesis of the yellow fever virus NS2B protein: effects on proteolytic processing, NS2B-NS3 complex formation, and viral replication | 3.6 | 175 | Citations (PDF) |
| 338 | Expression and identification of hepatitis C virus polyprotein cleavage products | 3.6 | 873 | Citations (PDF) |
| 339 | Cleavage at a novel site in the NS4A region by the yellow fever virus NS2B-3 proteinase is a prerequisite for processing at the downstream 4A/4B signalase site | 3.6 | 188 | Citations (PDF) |
| 340 | Characterization of the hepatitis C virus-encoded serine proteinase: determination of proteinase-dependent polyprotein cleavage sites | 3.6 | 626 | Citations (PDF) |
| 341 | Examples of expression systems based on animal RNA viruses: Alphaviruses and influenza virus | 6.8 | 11 | Citations (PDF) |
| 342 | Recombinant vaccinia virus producing the prM and E proteins of yellow fever virus protects mice from lethal yellow fever encephalitis | 2.3 | 127 | Citations (PDF) |
| 343 | Heterogeneity in envelope protein sequence and N-Linked glycosylation among yellow fever virus vaccine strains | 2.3 | 57 | Citations (PDF) |
| 344 | Processing of the yellow fever virus nonstructural polyprotein: a catalytically active NS3 proteinase domain and NS2B are required for cleavages at dibasic sites | 3.6 | 253 | Citations (PDF) |
| 345 | FLAVIVIRUS GENOME ORGANIZATION, EXPRESSION, AND REPLICATION | 9.1 | 1,937 | Citations (PDF) |
| 346 | Temperature sensitive shut-off of alphavirus minus strand RNA synthesis maps to a nonstructural protein, nsP4 | 2.3 | 79 | Citations (PDF) |
| 347 | Phosphorylation of sindbis virus nsP3 in vivo and in vitro | 2.3 | 106 | Citations (PDF) |
| 348 | Production of yellow fever virus proteins in infected cells: Identification of discrete polyprotein species and analysis of cleavage kinetics using region-specific polyclonal antisera | 2.3 | 141 | Citations (PDF) |
| 349 | Sequence of the 3? half of the Murray Valley encephalitis virus genome and mapping of the nonstructural proteins NS1, NS3, and NS5 | 1.9 | 22 | Citations (PDF) |
| 350 | Evidence that the N-terminal domain of nonstructural protein NS3 from yellow fever virus is a serine protease responsible for site-specific cleavages in the viral polyprotein. | 7.5 | 365 | Citations (PDF) |
| 351 | Yellow fever virus proteins NS2A, NS213, and NS4B: Identification and partial N-terminal amino acid sequence analysis | 2.3 | 113 | Citations (PDF) |
| 352 | Association of the sindbis virus RNA methyltransferase activity with the nonstructural protein nsP1 | 2.3 | 166 | Citations (PDF) |
| 353 | Multiple tachykinins are produced and secreted upon post-translational processing of the three substance P precursor proteins, α-, β-, and γ-preprotachykinin | 2.2 | 96 | Citations (PDF) |
| 354 | Nonstructural proteins nsP3 and nsP4 of Ross River and O'Nyong-nyong viruses: Sequence and comparison with those of other alphaviruses | 2.3 | 90 | Citations (PDF) |
| 355 | Use of enzyme immunoassay and nucleic acid hybridization for detecting Sindbis virus in infected mosquitoes | 1.6 | 11 | Citations (PDF) |
| 356 | Partial nucleotide sequence of St. Louis encephalitis virus RNA: Structural proteins, NS1, ns2a, and ns2b | 2.3 | 99 | Citations (PDF) |
| 357 | Conserved elements in the 3′ untranslated region of flavivirus RNAs and potential cyclization sequences | 4.1 | 340 | Citations (PDF) |
| 358 | Partial N-terminal amino acid sequences of three nonstructural proteins of two flaviviruses | 2.3 | 62 | Citations (PDF) |
| 359 | Sindbis virus mutant ts20 of complementation group E contains a lesion in glycoprotein E2 | 2.3 | 39 | Citations (PDF) |
| 360 | Partial nucleotide sequence of the Murray Valley encephalitis virus genome | 4.1 | 163 | Citations (PDF) |
| 361 | Neomycin Resistance as a Dominant Selectable Marker for Selection and Isolation of Vaccinia Virus Recombinants | 2.5 | 73 | Citations (PDF) |
| 362 | Biochemical studies of the maturation of the small sindbis virus glycoprotein E3 | 2.3 | 57 | Citations (PDF) |
| 363 | Complete nucleotide sequence of the genomic RNA of Sindbis virus | 2.3 | 447 | Citations (PDF) |
| 364 | Ross river virus 26 S RNA: Complete nucleotide sequence and deduced sequence of the encoded structural proteins | 2.3 | 142 | Citations (PDF) |
| 365 | The N-terminus of PE2 in Sindbis virus-infected cells | 2.3 | 15 | Citations (PDF) |
| 366 | Association of Sindbis virion glycoproteins and their precursors | 4.1 | 178 | Citations (PDF) |
| 367 | Isolation and characterization of the hydrophobic COOH-terminal domains of the Sindbis virion glycoproteins | 4.1 | 84 | Citations (PDF) |
| 368 | Synthesis, cleavage and sequence analysis of DNA complementary to the 26 S messenger RNA of Sindbis virus | 4.1 | 79 | Citations (PDF) |
| 369 | Escape from neutralizing antibodies by SARS-CoV-2 spike protein variants | 0.7 | 1,357 | Citations (PDF) |
| 370 | Engineered bacteria launch and control an oncolytic virus | 22.4 | 21 | Citations (PDF) |
